ArticleProceedings (Baylor University. Medical Center)2022
Malignant mixed epithelial and stromal tumor of the kidney with rhabdomyosarcomatous transformation presenting with gross hematuria.
Article in Proceedings (Baylor University. Medical Center), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant rhabdomyosarcoma associated with mixed epithelial and stromal tumor of the kidney (MESTK) is an exceptionally rare clinical phenomenon, with only two reported cases. Here, we describe the case of a middle-aged Middle Eastern woman with a left renal mass diagnosed as malignant MESTK with rhabdomyosarcomatous transformation. The patient initially presented with gross hematuria and was found to have a heterogenous 6.3 × 4.0 cm left renal mass, initially suspected to be renal cell carcinoma. She underwent nephrectomy with surgical resection of the tumor. Microscopic exam revealed neoplastic tissue composed of spindle and epithelial cells. The immunohistochemical analysis revealed positive staining for desmin, SMA, PR and negative staining for EMA, HMB 45, Melan A, and ER, consistent with MESTK with malignant rhabdomyosarcomatous transformation. The patient's whole-body positron emission tomography/computed tomography revealed no residual malignancy, and the patient currently remains under clinical observation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.